Skip to content
10-Q

Quarterly Report

Journey Medical Corp DERM

0001410578-25-001296

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Long Term Debt Q1 2025 · Mar 31, 2025 $23.11M
Long Term Debt Q1 2025 · Dec 31, 2024 $24.88M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $21.07M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $20.31M
Current Liabilities Q1 2025 · Mar 31, 2025 $40.22M
Current Liabilities Q1 2025 · Dec 31, 2024 $35.18M
Total Liabilities Q1 2025 · Mar 31, 2025 $63.42M
Total Liabilities Q1 2025 · Dec 31, 2024 $60.17M
Current Assets Q1 2025 · Mar 31, 2025 $53.99M
Current Assets Q1 2025 · Dec 31, 2024 $48.18M
Total Assets Q1 2025 · Mar 31, 2025 $84.96M
Total Assets Q1 2025 · Dec 31, 2024 $80.24M
Shares Diluted Q1 2025 · Mar 31, 2024 19.76M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$5.02M
Stockholders Equity Q1 2025 · Mar 31, 2024 $12.95M
Stockholders Equity Q1 2025 · Dec 31, 2023 $20.35M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.53
Eps Basic Q1 2025 · Mar 31, 2024 −$0.53
Sga Expense Q1 2025 · Mar 31, 2024 $8.42M
Rd Expense Q1 2025 · Mar 31, 2024 $7.88M
Net Income Q1 2025 · Mar 31, 2024 −$10.44M
Operating Income Q1 2025 · Mar 31, 2024 −$10.09M
Revenue Q1 2025 · Mar 31, 2024 $13.03M